Logo of the Belgian government
 
R_231

A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

KCE Reports 231

Reference KCE Reports 231
Type Health Technology Assessment (HTA)
Authors Hanquet Germaine, Christensen Hannah, Agnew Emily, Trotter Caroline, Robays Jo, Dubois Cécile, Devriese Stephan, Van De Sande Stefaan, Thiry Nancy
Report's Language The synthese is available in English. The report is available in English. The supplement is availabe in English.
Keywords Adolescent; Cost-Benefit Analysis; Costs and Cost Analysis; Infant; Meningococcal Vaccines; Neisseria meningitidis, Serogroup B
published on 14-10-2014